BIOLASE INC(BIOLQ.US)

Company Encyclopedia

BIOLASE INC

BIOLQ.US

1.378 T

BIOLQ.USMarket value -Rank by Market Cap -/-

Financial Score

22/01/2026 Update

Health Care EquipmentIndustry

Industry Ranking108/175

Industry medianC

Industry averageC

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreB
- ROE652.34%A
- Profit Margin-34.84%E
- Gross Margin40.39%B
Growth ScoreD
- Revenue YoY-7.44%D
- Net Profit YoY62.12%B
- Total Assets YoY-29.69%E
- Net Assets YoY-156.08%E
Cash ScoreD
- Cash Flow Margin-288.28%D
- OCF YoY-7.44%D
Operating ScoreA
- Turnover1.4A
Debt ScoreE
- Gearing Ratio112.11%E

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
Anson Group	5.25%	No Change	30/09/2024

News

Global computer vision in healthcare market to grow by $10.97 billion by 2030 with a CAGR of 31.1%. Report covers market trends and vendor analysis.

A recent market report on Computer Vision in Healthcare forecasts significant growth, with the global market expected to increase by USD 10.97 billion from 2025 to 2030. The market is projected to experience a remarkable Compound Annual Growth Rate (CAGR) of 31.1% during this period. The report offers a thorough analysis of the market, encompassing size, future projections, trends, factors driving growth, challenges, and an extensive vendor analysis of around 25 key players.

Unusual Whales·Yesterday at 02:51

Global wearable fall detector market to reach USD 3.7 billion by 2035, from USD 1.9 billion in 2025, at a CAGR of 6.6%.

In Newark, Delaware, as of January 21, 2026, the worldwide market for wearable fall detectors is worth $1.9 billion in 2025. Analysts forecast this market to grow to $3.7 billion by 2035, with a projected compound annual growth rate (CAGR) of 6.6% throughout the forecasted period. These insights are from a report by Future Market...

Unusual Whales·Yesterday at 01:13

12:11 ET Wearable Fall Detector Market Set to Reach USD 3.7 Billion by 2035, Driven by Aging Population and AI-Enabled Wearables

The global wearable fall detector market is projected to grow from USD 1.9 billion in 2025 to USD 3.7 billion by 2035, with a CAGR of 6.6%. Growth is driven by an aging population, preference for home care, and increased adoption of health-monitoring wearables. The wristband segment leads with a 38% market share, while home care applications account for 54%. Key growth markets include China and India, with major players like Philips and Apple. The market will experience phases of strong adoption, moderation, and innovation-driven rebound through 2035.

prnewswire·Yesterday at 01:12

prnewswire·Yesterday at 01:12

Global Achromatopsia Market to reach USD 191.22 million by 2032 with 7.58% CAGR growth, highlights genetic advancements.

Dublin - The global market for achromatopsia is projected to witness significant growth, with estimations indicating an increase from USD 121.99 million in 2026 to USD 191.22 million by 2032, representing a compound annual growth rate of 7.58%. This growth is attributed to advancements in genetic characterization, diagnostics, and treatment options within the field of achromatopsia. The market landscape for achromatopsia is outlined in a comprehensive research report available on ResearchAndMarkets.com.

Unusual Whales·Yesterday at 00:21

09:08 ET January Issue of Journal of Cardiac Failure-Intersections Examines How Innovation, Advanced Mechanical Support, and Prescribing Design Are Reshaping Heart Failure Care

The January issue of the Journal of Cardiac Failure-Intersections highlights advancements in heart failure care through innovation and multidisciplinary research. It features analyses on the impact of venture capital in diagnostics and therapeutics, original studies on atrial fibrillation during ECMO, and the development of a discrete choice experiment for polypill trials. The journal emphasizes the importance of aligning therapeutic design with clinician priorities to improve patient outcomes in heart failure care.

prnewswire·Yesterday at 22:12